Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

67.82 +0.74 (+1.10%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Volume	1,000,260
Open	67.34
Bid (Size)	66.80 (100)
Ask (Size)	69.22 (200)
Prev. Close	67.08
Today's Range	66.64 - 68.24
52wk Range	47.50 - 82.22
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Cash-Producing Stocks with Exciting Potential

Today 0:35 EDT

Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain ...

Via StockStory

2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore

April 09, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

Performance

YTD	-3.5%	-3.5%
1 Month	+0.0%	+0.0%
3 Month	-6.0%	-6.0%
6 Month	+4.2%	+4.2%
1 Year	+11.8%	+11.8%

More News

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

April 08, 2026

Via StockStory

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

March 24, 2026

Via StockStory

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

March 06, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Reports Mixed Q4 2025 Results with Revenue Beat and Unexpected Loss ↗

February 17, 2026

Via Chartmill

HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation ↗

February 17, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Growth and Technical Setup ↗

January 29, 2026

Via Chartmill

2 Reasons to Like HALO (and 1 Not So Much)

February 24, 2026

Via StockStory

Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales

February 17, 2026

Via StockStory

Halozyme Therapeutics Inc (NASDAQ:HALO) Passes Minervini Trend Template and High Growth Momentum Screen ↗

January 17, 2026

Via Chartmill

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

Via StockStory

3 Small-Cap Stocks with Solid Fundamentals

February 08, 2026

Via StockStory

3 Growth Stocks Set to Flourish

February 01, 2026

Via StockStory

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

Via StockStory

Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

January 28, 2026

Via StockStory

HALO Stock Edges Up 3% On Upbeat Multi-Year Revenue Guidance, Surf Bio Acquisition ↗

January 28, 2026

Via Stocktwits

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

January 27, 2026

Via StockStory

Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks

January 25, 2026

Via StockStory

2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗

January 24, 2026

Via The Motley Fool

Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)

January 21, 2026

Via StockStory

Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

January 19, 2026

Via StockStory

Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty ↗

January 19, 2026

Via The Motley Fool

Q3 Therapeutics Earnings: Halozyme Therapeutics (NASDAQ:HALO) Earns Top Marks

January 18, 2026

Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 67.82

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 04/10/26 04:00 PM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.65B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.